{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T10:48:17Z","timestamp":1778410097806,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T00:00:00Z","timestamp":1595808000000},"content-version":"vor","delay-in-days":26,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012141","name":"University Hospitals Bristol NHS Foundation Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["phiro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physics and Imaging in Radiation Oncology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.phro.2020.07.005","type":"journal-article","created":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T13:51:29Z","timestamp":1597067489000},"page":"66-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["A study of the clinical, treatment planning and dosimetric feasibility of dose painting in external beam radiotherapy of prostate cancer"],"prefix":"10.1016","volume":"15","author":[{"given":"Steve W.","family":"Blake","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Stapleton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sian","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janice","family":"Ash-Miles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Dennis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Masson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawn","family":"Bowers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serena","family":"Hilman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.phro.2020.07.005_b0005","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1200\/JCO.2005.05.2530","article-title":"Dose-Response in Radiotherapy for Localized Prostate Cancer: Results of the Dutch Multicenter Randomized Phase III Trial Comparing 68 Gy of Radiotherapy With 78 Gy","volume":"24","author":"Peeters","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.phro.2020.07.005_b0010","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1080\/0284186X.2017.1415457","article-title":"Dose painting of prostate cancer based on Gleason score correlations with apparent diffusion coefficients","volume":"57","author":"Gr\u00f6nlund","year":"2017","journal-title":"Acta Oncol"},{"key":"10.1016\/j.phro.2020.07.005_b0015","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2217\/iim.11.10","article-title":"Functional MRI for tumor delineation in prostate radiation therapy","volume":"3","author":"Van Der Heide","year":"2011","journal-title":"Imaging Med"},{"key":"10.1016\/j.phro.2020.07.005_b0020","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.clon.2015.09.006","article-title":"Prostate Dose-painting Radiotherapy and Radiobiological Guided Optimisation Enhances the Therapeutic Ratio","volume":"28","author":"Uzan","year":"2016","journal-title":"Clin Oncol"},{"key":"10.1016\/j.phro.2020.07.005_b0025","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.semradonc.2010.10.001","article-title":"Molecular imaging-based dose painting: a novel paradigm for radiation therapy prescription","volume":"21","author":"Bentzen","year":"2011","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.phro.2020.07.005_b0030","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/1745-6215-12-255","article-title":"Single blind randomized Phase III trial to investigate the benefit of a focal lesion ablative microboost in prostate cancer (FLAME-trial): Study protocol for a randomized controlled trial","volume":"12","author":"Lips","year":"2011","journal-title":"Trials"},{"key":"10.1016\/j.phro.2020.07.005_b0035","unstructured":"Cruickshank C. PIVOTALboost RADIOTHERAPY PLANNING AND DELIVERY GUIDELINES A phase III randomised controlled trial of prostate and pelvis versus prostate alone radiotherapy with or without prostate boost PROTOCOL Version: FINAL VERSION 2. 2017."},{"key":"10.1016\/j.phro.2020.07.005_b0040","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.ijrobp.2019.11.402","article-title":"Standard and Hypofractionated Dose Escalation to Intraprostatic Tumor Nodules in Localized Prostate Cancer: Efficacy and Toxicity in the DELINEATE Trial","volume":"106","author":"Murray","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2020.07.005_b0045","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.phro.2018.03.008","article-title":"Analysis of intra-fraction prostate motion and derivation of duration-dependent margins for radiotherapy using real-time 4D ultrasound","volume":"5","author":"Pang","year":"2018","journal-title":"Phys Imag Radiat Oncol"},{"key":"10.1016\/j.phro.2020.07.005_b0050","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.clon.2007.01.317","article-title":"28 Quality Assurance of Dosimetry in Centres participating in the CHHIP Prostate Radiotherapy Trial","volume":"19","author":"Naismith","year":"2007","journal-title":"Clin Oncol"},{"key":"10.1016\/j.phro.2020.07.005_b0055","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.ijrobp.2018.04.008","article-title":"In Vivo Validation of Elekta\u2019s Clarity Autoscan for Ultrasound-based Intrafraction Motion Estimation of the Prostate During Radiation Therapy","volume":"102","author":"Grimwood","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2020.07.005_b0060","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.radi.2017.07.003","article-title":"Intrafraction monitoring of prostate motion during radiotherapy using the Clarity \u00ae Autoscan Transperineal Ultrasound (TPUS) system","volume":"23","author":"Richardson","year":"2017","journal-title":"Radiography"},{"key":"10.1016\/j.phro.2020.07.005_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/7569590","article-title":"The Use of Ultrasound Imaging in the External Beam Radiotherapy Workflow of Prostate Cancer Patients","volume":"2018","author":"Camps","year":"2018","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.phro.2020.07.005_b0070","doi-asserted-by":"crossref","DOI":"10.1007\/s00330-011-2377-y","article-title":"ESUR prostate MR guidelines 2012","author":"Barentsz","year":"2012","journal-title":"Eur Radiol"},{"key":"10.1016\/j.phro.2020.07.005_b0075","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S1470-2045(15)00280-6","article-title":"Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial","volume":"16","author":"Wilkins","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.phro.2020.07.005_b0080","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1470-2045(11)70293-5","article-title":"Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial","volume":"13","author":"Dearnaley","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.phro.2020.07.005_b0085","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S1470-2045(16)30102-4","article-title":"Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial","volume":"17","author":"Dearnaley","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.phro.2020.07.005_b0090","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1118\/1.598248","article-title":"A technique for the quantitative evaluation of dose distributions","volume":"25","author":"Low","year":"1998","journal-title":"Med Phys"},{"key":"10.1016\/j.phro.2020.07.005_b0095","doi-asserted-by":"crossref","first-page":"e908","DOI":"10.1002\/mp.13162","article-title":"Patient-specific validation of deformable image registration in radiation therapy: Overview and caveats","volume":"45","author":"Paganelli","year":"2018","journal-title":"Med Phys"},{"key":"10.1016\/j.phro.2020.07.005_b0100","doi-asserted-by":"crossref","first-page":"6090","DOI":"10.1118\/1.4931417","article-title":"Technical Note: MRI only prostate radiotherapy planning using the statistical decomposition algorithm","volume":"42","author":"Siversson","year":"2015","journal-title":"Med Phys"},{"key":"10.1016\/j.phro.2020.07.005_b0105","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.radonc.2018.12.029","article-title":"Applying a commercial atlas-based synthetic Computed Tomography algorithm to patients with hip prostheses for prostate Magnetic Resonance-only radiotherapy","volume":"133","author":"Wyatt","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2020.07.005_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1088\/1361-6560\/aaaca4","article-title":"MRI-only treatment planning: Benefits and challenges","volume":"63","author":"Owrangi","year":"2018","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.phro.2020.07.005_b0115","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.phro.2019.07.002","article-title":"Planning feasibility of extremely hypofractionated prostate radiotherapy on a 1.5 T magnetic resonance imaging guided linear accelerator","volume":"11","author":"Den Hartogh","year":"2019","journal-title":"Phys Imag Radiat Oncol"},{"key":"10.1016\/j.phro.2020.07.005_b0120","article-title":"ISRCTN - ISRCTN80146950: A phase III randomised controlled trial of prostate and pelvis versus prostate alone radiotherapy with or without prostate boost","author":"Hassan","year":"2018","journal-title":"Web Page"},{"key":"10.1016\/j.phro.2020.07.005_b0125","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0360-3016(00)00518-6","article-title":"The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy","volume":"47","author":"van Herk","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2020.07.005_b0130","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/jmrs.224","article-title":"Initial experience with intra-fraction motion monitoring using Calypso guided volumetric modulated arc therapy for definitive prostate cancer treatment","volume":"64","author":"Bell","year":"2017","journal-title":"J Med Radiat Sci"},{"key":"10.1016\/j.phro.2020.07.005_b0135","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1177\/1533034617728643","article-title":"Intrafractional Tracking Accuracy of a Transperineal Ultrasound Image Guidance System for Prostate Radiotherapy","volume":"16","author":"Yu","year":"2017","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.phro.2020.07.005_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.clon.2016.07.002","article-title":"Implementation of a Daily Transperineal Ultrasound System as Image-guided Radiotherapy for Prostate Cancer","volume":"29","author":"Hilman","year":"2017","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.phro.2020.07.005_b0145","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.clon.2018.08.001","article-title":"Adaptive Radiotherapy Enabled by MRI Guidance","volume":"30","author":"Hunt","year":"2018","journal-title":"Clin Oncol"},{"key":"10.1016\/j.phro.2020.07.005_b0150","first-page":"67","article-title":"Proton beam therapy for localized prostate cancer 101: basics, controversies, and facts","volume":"16","author":"Wisenbaugh","year":"2014","journal-title":"Rev Urol"},{"key":"10.1016\/j.phro.2020.07.005_b0155","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.phro.2018.06.002","article-title":"A biological modelling based comparison of radiotherapy plan robustness using photons vs protons for focal prostate boosting","volume":"6","author":"Pedersen","year":"2018","journal-title":"Phys Imag Radiat Oncol"},{"key":"10.1016\/j.phro.2020.07.005_b0160","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.radonc.2019.06.023","article-title":"Stereotactic body radiation therapy with optional focal lesion ablative microboost in prostate cancer: Topical review and multicenter consensus","volume":"140","author":"Draulans","year":"2019","journal-title":"Radiother Oncol"}],"container-title":["Physics and Imaging in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405631620300397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405631620300397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:12:37Z","timestamp":1762503157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405631620300397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":32,"alternative-id":["S2405631620300397"],"URL":"https:\/\/doi.org\/10.1016\/j.phro.2020.07.005","relation":{},"ISSN":["2405-6316"],"issn-type":[{"value":"2405-6316","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A study of the clinical, treatment planning and dosimetric feasibility of dose painting in external beam radiotherapy of prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Physics and Imaging in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phro.2020.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V. on behalf of European Society of Radiotherapy & Oncology.","name":"copyright","label":"Copyright"}]}}